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Abstract
Objectives Diffusion-weighted MRI provides information regarding body water movement following death, which may be an
imaging marker of post-mortem interval (time since death; PMI) or maceration (degree of tissue degradation during intra-uterine
retention) in perinatal deaths. Our aim was to evaluate the relationship between maceration, PMI and body organ apparent
diffusion coefficient (ADC) values in a cohort of subjects across a wide gestational range.
Materials Whole body post-mortem MRI with diffusion-weighted imaging (DWI) sequences were performed at 1.5 T, with b
values of 0, 500 and 1000 mm2/s. Mean ADC values were calculated from regions of interest (ROIs) placed in the lungs,
myocardium, spleen, renal cortex, liver and psoas muscle by two independent readers. Multivariable regression analysis was
performed against PMI, gestational age, post-mortem weight, maceration score and gender.
Results Eighty perinatal deaths were imaged with mean gestational age of 32 weeks (18–41 weeks), of which 49 (61.3%) were
male. The mean PMI was 8 days (1–18 days). Maceration scores were statistically significant predictive factors for ADC values
in all included body organs except the lungs, but PMI was not a predictor for ADC values in any body organ. In the absence of
maceration (n = 14), PMI was not statistically associated with ADC values in any of the body areas. The ratio of agreement in the
majority of body areas was close to 1 (range between 0.95 and 1.10).
Conclusion Maceration, not PMI, is significantly associated with ADC values in perinatal deaths. Further research is needed to
understand organ-specific changes in the post-mortem period.
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Abbreviations
ADC Apparent diffusion coefficient
DWI Diffusion-weighted (magnetic resonance)
imaging
(PM)MR (Post-mortem) magnetic resonance imaging
PMI Post-mortem interval
ROI Region of interest
Introduction
Post-mortem magnetic resonance imaging (PMMR) has been
shown to have a high diagnostic accuracy in identification of
perinatal abnormalities and cause of death [1, 2]. Diffusion-
weighted imaging (DWI), a sequence that is used in PMMR
imaging protocols [3], derives contrast from the differences in
movement of water molecules within various tissues [4] and can
be indirectly quantified using the apparent diffusion coefficient
(ADC) [5]. This value can provide information relating to the
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microscopic structure and functional changes at a cellular level
within body organs where structures with high cellularity (i.e.
causing restriction of movement of water molecules) demon-
strate low ADC values, compared to less cellular structures with
higher ADC values [6]. In live children, this imaging sequence
has shown to have promising clinical uses, such as for the as-
sessment of tumour response to treatment [7] and in the identifi-
cation of inflammatory changes (such as in inflammatory bowel
disease [8] and enthesitis-related arthritis [9]).
The application of DWI in the post-mortem setting is ap-
pealing as it (a) does not require the administration of an
exogenous contrast agent, (b) the irreversible and progressive
cellular changes that occur as a consequence of autolysis
should be detectable and (c) could result in ADC values that
change predictably over time, and may allow the estimation of
time since death, or post-mortem interval (PMI).
Nevertheless, imaging assessment of perinatal post-mortem
tissue has several confounders. In addition to autolysis (i.e.
the enzymatic degradation of tissue following death), foetuses
which have suffered intra-uterine demise and retention prior to
delivery undergo a process of maceration (i.e. tissue degener-
ation within a fluid-filled cavity (amniotic fluid)). Figure 1
provides a diagrammatical representation of the relative
timing of these processes. Given that exact knowledge of an
intra-uterine death is frequently unknown (and thus the timing
of intra-uterine retention inaccurate), the degree of maceration
at autopsy by external assessment is commonly used as a
subjective, surrogate marker to estimate intra-uterine retention
time [10].
Reports of PMMR imaging in the medical literature which
have used DWI have shown that in the foetal brain (specifi-
cally the basal ganglia) [11] and lung [12] the ADC value
changes are associated with PMI. Maceration was also found
to affect ADC values in most areas of the foetal brain, but
other body organs have not been comprehensively evaluated.
The aim of this study was therefore to evaluate the relation-
ship between maceration, PMI and body organ ADC values
across a wide gestational age range in the setting of perinatal
death. If the ADC values in body organs are found to be robust
marker of PMI or maceration, this could have implications for
the investigation of intra-uterine foetal deaths, especially
where timing may be medico-legally important.
Methods
Study cohort
Written informed consent was obtained from all parents of
participants for clinical pre-autopsy PMMR, as part of our
institution’s post-mortem imaging protocol. DWI sequences
were prospectively performed on all post-mortem foetal, still-
birth and early neonatal deaths referred to our institution from
May 2013 to September 2016 (40 months). Cases in which the
DWI imaging was of inadequate quality, incomplete, or where
there was significant organ abnormality on imaging or at au-
topsy were excluded. Bodies were stored in the mortuary at
4 °C within 24 h of delivery and PMMR was performed dur-
ing dedicated research imaging lists to prevent any disruption
to usual clinical services.
Demographic included age at time of death (for neonatal
deaths, in days), gestational age (in weeks) and post-mortem
interval (PMI, days from delivery to imaging). Intra-uterine
retention interval (time between foetal death and delivery/ex-
traction) was not recorded due to unreliable timing and incon-
sistent documentation in the notes. For this reason, we used
maceration score (scored subjectively by the duty pathologist:
0–none, 1–mild or moderate, 2–established [10]).
Magnetic resonance imaging
All MR imaging was performed at 1.5 T (Avanto, Siemens
Medical Solutions, Erlangen, Germany) with a conventional
phase array body coil. Body imaging included isovolumetric
T1- and T2-weighted imaging for the whole body (neck to
feet) with additional isovolumetric T2-weighted constructive
interface stead state (CISS) sequences covering the thorax (for
cardiac anomalies) and a 2D axial T2-weighted inversion re-
covery sequence of the body, according to published protocols
[3]. The coil used was dependent on patient size, selected to
allow for best image quality.
Diffusion-weighted imaging sequences were performed
using single-shot spin echo-planar imaging (EPI) in the axial
plane, with the following parameters: 19 slices in three non-
collinear axis directions, EPI factor 95, TR 2700 ms; TE
96ms; FOV 230 mm; 128 × 128 matrix, 5-mm-slice thickness
with 1-mm gap, acquisition time 90 s. Diffusion gradient
values were b = 0, 500 and 1000 s/mm2.
DWI analysis
From the native DWI acquisition, ADC maps were obtained
on the acquisition console (Syngo, Siemens Medical
Solutions, Erlangen, Germany). Data was then transferred to
Osirix (open source DiCOM viewer: http://www.osirix-
viewer.com) for ADC measurements in different regions of
interest (ROI). Circular ROIs were drawn manually and
plotted on ADC maps for all cases by two independent
readers blinded to one another’s findings and also to the
post-mortem report. Where there was difficulty in identifying
the delineation of the target organ, cross-referencing was
made to the isovolumetric T2 sequences obtained during the
same MRI examination for anatomical information. The
readers read the cases once. Both readers were qualified pae-
diatric radiologists with 7 years experience each.
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The ROIs were placed on the following body locations
(Fig. 2):
1) Lung: obtained within the largest region of ‘normal’ lung
parenchyma (i.e. non-consolidated regions for neonatal
deaths, and for all cases—not including any pleural
effusions).
2) Myocardium: within the intraventricular septum or left
ventricular muscle, whichever allowed the largest ROI
volume to be obtained.
3) Right renal cortex: avoiding any renal pelvis.
4) Liver: within the right lobe of the liver to obtain the most
representative ROI sample.
5) Spleen: within the centre of the organ to include the larg-
est ROI possible
6) Right psoas muscle: used as a control value.
For each ROI, a mean ADC value (× 10−5 mm2/s) ±
standard deviation (SD) was obtained. The circular area
for the ROI was drawn to include as much of the target
organ as possible, whilst maintaining a relative SD < 10%
of the mean to ensure homogeneity, typically < 25mm2.
Size-specific ROIs were used for each individual case
rather than choosing a fixed ROI, due to the range of
foetal sizes (weight and gestation range given in Table
1) in our sample size. Where a valid ADC value for an
organ could not be obtained (either due to a small organ
inclusion area on the ADC map or significant artefact),
then this was left blank or unrecorded.
Temperature correction for ADC values was not applied
given that our sample included only post-mortem cases, im-
aged and stored at comparable temperatures. No comparison
or extrapolation of our values with live cases was performed.
Fig. 1 Illustration of the timing of
events where intra-uterine foetal
demise has occurred, to highlight
the terms ‘post-mortem interval
(PMI)’ and intra-uterine death in-
terval. The degradation of tissue
via autolysis (green arrow) occurs
after the death of the foetus,
whereas those of maceration (red
arrow) occur only whilst the foe-
tus remains in utero. In cases
where the foetus is born alive and
subsequently dies, maceration by
definition will not have occurred
and the body will only undergo
autolysis
Fig. 2 Foetal thoraco-abdominal
post-mortem axial apparent diffu-
sion coefficient (ADC) maps
from DWI sequences (a–d) in a
32 gestational age foetus. The
axial slices illustrate the lungs and
myocardium (a), liver and spleen
(b), kidneys (c) and psoas muscle
(d) with corresponding regions of
interest drawn
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Statistical analysis
Multilevel models were fitted for each ROI with mean
corrected ADC values (10−5 mm2/s) with the outcome
variable subject and reader both included as complete
cross-classified random intercepts. Fixed effect predictor
variables include maceration scores (MAC), post-mortem
interval (PMI), gestational age, gender and post-mortem
weight. Given a prior publication stating maceration to
be a strongest predictor in ADC values for post-mortem
foetal brain [11], we extracted a sub-group of cases in
whom maceration could not have occurred (i.e. neonatal
deaths; babies who were born alive and subsequently
died). The mean corrected ADC values for each ROI were
plotted against the post-mortem interval and the adjusted
R2 estimates were calculated to summarise the strength of
any linear relationships for the various body organs. This
subsample contained 14 patients, and therefore given the
low sample size, it was not possible to adjust for multiple
predictors.
To measure inter-reader variability, Bland-Altman plots
were constructed with 95% limits of agreement on the ratio
between the two reader mean ADC values. The ratios of the
two measurements were calculated, instead of the absolute
difference, because agreement is dependent on the scale of
the ADC measurement. All analyses were carried out in R
version 3.3.0 and the R package lme4 version 1.1.141 was
used for multilevel analysis.
Results
Study sample
We identified 80 (49, 61.3% male) perinatal deaths for
inclusion in the study: 14 (17.5%) neonatal deaths,
21(26.2%) termination of pregnancies (TOP), 2 (2.5%)
miscarriages and 43 (53.8%) stillbirth/intra-uterine deaths.
The patient demographics are given in Table 1. Table 2
lists the mean ADC values for the different body areas
based on the total number of readings obtained by both
readers.
Multivariate analysis
Using multilevel modelling, six prediction models were fitted
for the lungs, myocardium, renal cortex, liver, spleen and
psoas muscle. Maceration score was a statistically significant
predictor for ADC values in all body areas except the lungs
(Table 3). The other five models predict an increase in ADC
values of between 93.82 (spleen, 95% CI 31.19–156.4) and
321.8 (myocardium, 95% CI 230.1–413.5) in patients with a
maceration score of 2 (in comparison with maceration score
0). Post-mortem interval (PMI) was not a predictor for ADC
values for any of the body organs after adjusting for all other
predictor variables.
Non-macerated perinatal deaths
In order to assess the relative contribution of maceration, we
identified 14 neonatal deaths (7 males; 50%) which by defi-
nition had not undergone maceration. This sub-group had me-
dian PMI of 5 days (range 1–12 days) with median PMweight
of 2.625 kg (range 0.339–4.335 kg). PMI was not a significant
predictor of ADC values in any body area in this subsample.
Reproducibility
Readers had the highest agreement in the right psoas muscle,
withmean ratio of 1.04 and 95% limits of agreement (LOA) of
the ratios between 0.80 and 1.35. Agreement was poorest in
the spleen, with mean ratio of 1.02 and 95% LOA between
0.42 and 2.44. The mean ratio of agreement in all body areas
was close to 1 (range between 0.95 and 1.10).
Table 1 Demographic data of the
80 perinatal deaths included in
this study. The neonatal sub-
group (n = 14) were delivered
alive but died within the first
month of life.
Case group N Mean Median IQR Range
Age at death (days) Neonatal deaths 14 7 1 0, 14.8 0–25
Gestational age
(weeks)
Neonatal deaths 14 34 37 33, 40 22–40
Gestational age
(weeks)
Stillbirths, miscarriages and
terminations*
66 32 34 27, 38 18–41
Post-mortem weight
(kg)
All cases 80 2.06 2.292 0.783,
3.006
0.258–4.73
Post-mortem interval
(days)
All cases 80 8 7.5 5, 10 1–18
*The remainder of our cases which were not neonatal deaths were born without signs of life. Their date of death
and date of birth are the same and age at death is therefore 0 days
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Discussion
This study found that the maceration score but not PMI was
significantly associated with post-mortem perinatal ADC
body organ values. Caution should therefore be exercised
when interpreting DWI PMMR to avoid attributing ADC
changes to post-mortem interval.
The association of maceration with ADC values is support-
ed in part by a previous study assessing post-mortem foetal
brain ADC values, where this played a role in all regions of the
brain analysed. Maceration is usually assessed at autopsy by
external appearances, including skin changes, umbilical cord
discoloration and cranial collapse, but the underlying cellular
process remains poorly understood [10]. Changes in mem-
brane permeability, redistribution of magnetization between
compartments and increased diffusivity within the remaining
extracellular space may all account for the diffusivity changes
observed in our study [13] giving differences in ADC values.
Clearly, a combination of autolysis and maceration contribute
to the changes seen in this study.
When we analysed a subset of non-macerated foetuses, we
did not find an underlying effect of post-mortem interval on
ADC changes. Whilst previous studies in perinatal deaths
have not been performed, a recently published study of 19
adult post-mortem cases [14] found that the ADC values of
the liver did not significantly changewith time (in hours) since
death, with temperature changes accounting for a greater ef-
fect. Nevertheless, the ADC values in this study were mea-
sured at two hourly intervals over 16 h, and this may not have
been enough time for effects to be observed.
Previous work performed for a set of 15 foetuses and neo-
nates reported that ADC changes in the lung may be correlated
to PMI [12]; however, in our larger cohort, we could not repro-
duce those findings. Of the 15 subjects that were analysed in the
comparator study, the majority (n = 10) were estimated to have
undergone in-utero retention ranging from between 0.5 and
2 days prior to delivery, with 4 subjects allocated a maceration
score of ≥ 1 at autopsy. Due to the small sample size, neonatal
deaths were not compared to intra-uterine deaths and the report-
ed changes in lung ADC values with time may have therefore
been a property of underlying maceration and autolysis rather
than post-mortem interval.
Although we have assessed the use of ADC values in the
largest perinatal population studied to date, our study has
several limitations, with relatively small sample size and
only fair inter-reader reproducibility. We speculate that this
may be due to inter-observer variation in ROI creation, and
limited experience in analysing post-mortem DWI imaging.
We also recognise that the use of size-specific ROIs may
have generated further variation, but a fixed size ROI would
not have yielded accurate results across the range of foetal
weights and gestations in our sample size. There may have
been some restrictions in our technique, as all of our cases
were imaged at 1.5 T and not 3 T. A higher magnetic field
strength could have yielded greater image contrast for the
anatomical referencing on isovolumetric T2 sequences to aid
placement of body organ ROIs [15]; however, the accuracy
of ADC values on high-field-strength MRI in the post-
mortem setting has yet to be evaluated, and may be more
susceptible to field inhomogeneity and artefacts [16]. In ad-
dition, whilst we used standard b values at 0, 500 and
1000 s/mm2, these may not be optimal for post-mortem
imaging at low temperatures and truly quantitative imaging
across this range could be useful in this setting.
Nevertheless, our imaging techniques were standardised
across all our subjects in this study following the same
MRI protocol. We did not apply temperature correction to
our data as the correlations and multivariate analysis would
have been unaffected and we were not comparing our data
with live subjects.
In addition, the usage of a maceration score is subjec-
tive, and higher scores do not always correlate with longer
intra-uterine retention times [17]. Ideally, investigating the
true effect of maceration would require knowing precisely
the intra-uterine retention period. This is challenging in
most intra-uterine deaths where the exact time of death
is unknown (Fig. 1), but this may be possible following
feticide for termination of pregnancy which could be
assessed in future work. Equally, a larger subset of non-
macerated cases could be investigated in more detail. It is
clear that the cellular changes that are detected by DWI
are complex and related to several factors, and thus we
urge caution if considering using these features in medi-
colegal and forensic cases.
Table 2 Summary of body organ
ADC measurements (×10−5 mm2/
s) in all 80 perinatal death cases,
by both readers. The N numbers
states the number of observations
that the mean and range ADC
values are derived from (i.e. if
both readers could obtain an ADC
score for all cases, then N = 160)
N (total no. observations) Median Mean Range IQR SD
Lung ADC 145 431 448 171–1073 375, 514 45
Myocardium ADC 136 610 615 224–1231 399, 783 58
Right renal cortex ADC 160 422 454 195–1046 315, 531 48
Liver ADC 159 450 439 66–829 279, 581 50
Spleen ADC 148 276 329 66–857 221, 386 64
Right psoas ADC 159 585 594 352–1069 486, 687 65
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Table 3 Stepwise multivariate linear models. Multivariate linear regression, using potential predictors of reader, maceration score, gestational age,
gender, postmortem (PM) weight and postmortem interval (PMI) in each model. Statistically significant results are highlighted in bold and in italics
Dependent variable Independent variables B s.e. 95% CI for B p value
Lower Upper
Lung (Constant) 417.2 128.1 – – –
Maceration score 1 (ref = 0) 30.04 42.76 − 53.78 113.9 0.485
Maceration score 2 (ref = 0) 11.13 30.86 − 49.36 71.61 0.720
Gestational age (weeks) − 1.363 4.996 − 11.16 8.429 0.786
Gender (ref = female) − 3.037 26.64 − 55.25 49.18 0.910
PM weight (kg) 6.523 25.67 − 43.79 56.84 0.800
PMI 6.949 4.138 − 1.162 15.06 0.098
Myocardium (Constant) 400.2 193.2 – – –
Maceration score 1 (ref = 0) 247.6 65.97 118.3 376.9 < 0.001
Maceration score 2 (ref = 0) 321.8 46.79 230.1 413.5 < 0.001
Gestational age (weeks) 3.674 7.536 − 11.1 18.44 0.628
Gender (ref = female) 0.618 40.91 − 79.56 80.8 0.988
PM weight (kg) − 64.95 38.93 − 141.2 11.35 0.100
PMI 7.468 6.344 − 4.966 19.9 0.244
Spleen (Constant) 345.1 134.1 – – –
Maceration score 1 (ref = 0) 69.42 42.34 − 13.57 152.4 0.106
Maceration score 2 (ref = 0) 93.82 31.95 31.19 156.4 0.005
Gestational age (weeks) − 0.814 5.127 − 10.86 9.234 0.874
Gender (ref = female) 19.7 27.62 − 34.43 73.83 0.478
PM weight (kg) − 57.09 25.62 − 107.3 −6.875 0.029
PMI 8.328 4.306 − 0.111 16.77 0.057
Right renal cortex (Constant) 486.5 180.1 – – –
Maceration score 1 (ref = 0) 111.6 57.66 − 1.452 224.6 0.057
Maceration score 2 (ref = 0) 153.5 43.24 68.72 238.2 0.001
Gestational age (weeks) − 4.731 6.902 − 18.26 8.797 0.495
Gender (ref = female) 31.01 37.31 − 42.12 104.1 0.409
PM weight (kg) − 22.15 34.8 − 90.36 46.06 0.526
PMI 7.982 5.788 − 3.363 19.33 0.172
Liver (Constant) 489.5 154.5 – – –
Maceration score 1 (ref = 0) 142.6 49.61 45.39 239.8 0.005
Maceration score 2 (ref = 0) 209.9 37.25 136.9 282.9 < 0.001
Gestational age (weeks) − 5.403 5.940 − 17.04 6.239 0.366
Gender (ref = female) − 41.84 32.13 − 104.8 21.13 0.197
PM weight (kg) 1.241 29.93 − 57.43 59.91 0.967
PMI 4.468 5.000 − 5.333 14.27 0.375
Right psoas (Constant) 501.0 116.3 – – –
Maceration score 1 (ref = 0) 83.63 37.22 10.68 156.6 0.028
Maceration score 2 (ref = 0) 161.3 27.91 106.6 216.0 < 0.001
Gestational age (weeks) 1.734 4.469 − 7.025 10.49 0.699
Gender (ref = female) 48.53 24.10 1.295 95.77 0.048
PM weight (kg) − 35.18 22.56 − 79.39 9.034 0.123
PMI − 0.187 3.741 − 7.520 7.146 0.960
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Conclusion
The degree of maceration plays an important role when
interpreting the post-mortem body organ ADC values, but
we did not find a significant correlation with PMI even in
cases where maceration was excluded. Further research is
needed to understand the organ-specific changes during mac-
eration for potential timing of intra-uterine demise in cases of
stillbirth.
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